"NF-kappa B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.
Descriptor ID |
D016328
|
MeSH Number(s) |
D12.776.260.600 D12.776.660.600 D12.776.930.600
|
Concept/Terms |
NF-kappa B- NF-kappa B
- kappa B Enhancer Binding Protein
- NF-kappaB
- NF kappaB
- Transcription Factor NF-kB
- Factor NF-kB, Transcription
- NF-kB, Transcription Factor
- Transcription Factor NF kB
- NF-kB
- NF kB
- Immunoglobulin Enhancer-Binding Protein
- Enhancer-Binding Protein, Immunoglobulin
- Immunoglobulin Enhancer Binding Protein
- Nuclear Factor kappa B
|
Below are MeSH descriptors whose meaning is more general than "NF-kappa B".
Below are MeSH descriptors whose meaning is more specific than "NF-kappa B".
This graph shows the total number of publications written about "NF-kappa B" by people in this website by year, and whether "NF-kappa B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 7 | 1 | 8 |
1995 | 5 | 1 | 6 |
1996 | 6 | 6 | 12 |
1997 | 9 | 3 | 12 |
1998 | 6 | 8 | 14 |
1999 | 15 | 5 | 20 |
2000 | 18 | 12 | 30 |
2001 | 23 | 9 | 32 |
2002 | 25 | 10 | 35 |
2003 | 31 | 26 | 57 |
2004 | 28 | 22 | 50 |
2005 | 32 | 21 | 53 |
2006 | 28 | 26 | 54 |
2007 | 30 | 28 | 58 |
2008 | 27 | 21 | 48 |
2009 | 25 | 34 | 59 |
2010 | 28 | 24 | 52 |
2011 | 20 | 33 | 53 |
2012 | 27 | 30 | 57 |
2013 | 14 | 16 | 30 |
2014 | 11 | 23 | 34 |
2015 | 11 | 24 | 35 |
2016 | 9 | 19 | 28 |
2017 | 12 | 24 | 36 |
2018 | 7 | 14 | 21 |
2019 | 5 | 12 | 17 |
2020 | 6 | 9 | 15 |
2021 | 6 | 9 | 15 |
2022 | 3 | 11 | 14 |
2023 | 4 | 8 | 12 |
2024 | 1 | 5 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "NF-kappa B" by people in Profiles.
-
CD24 negativity reprograms mitochondrial metabolism to PPARa and NF-?B-driven fatty acid ?-oxidation in triple-negative breast cancer. Cancer Lett. 2024 Apr 10; 587:216724.
-
Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy. Life Sci Alliance. 2024 Apr; 7(4).
-
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-?B Signaling in Patients with Pancreatic Cancer. Clin Cancer Res. 2024 02 01; 30(3):542-553.
-
Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis. Kidney Int. 2024 Apr; 105(4):775-790.
-
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nat Commun. 2024 Jan 02; 15(1):180.
-
[Zhuyu Pills promote polarization of macrophages toward M2 phenotype to prevent atherosclerosis via PPAR?/NF-?B signaling pathway]. Zhongguo Zhong Yao Za Zhi. 2024 Jan; 49(1):243-250.
-
Autoantibodies against type I IFNs in humans with alternative NF-?B pathway deficiency. Nature. 2023 Nov; 623(7988):803-813.
-
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression. Clin Cancer Res. 2023 11 01; 29(21):4464-4478.
-
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer. Cancer Res. 2023 10 02; 83(19):3284-3304.
-
Got PIDD1? Natural killer cells clear polyploid cells to ensure a balanced genome. EMBO J. 2023 10 16; 42(20):e115307.